Overview
Balance Sheet
Cash Flow
Growth Analysis
2024
2023
2022
2020
2019
Profitability Metrics
Gross Margin
87.17%
Operating Margin
83.57%
Net Margin
48.21%
Efficiency Metrics
Revenue per Expense Ratio
6.09
R&D as % of Revenue
0.00%
Earnings Quality
EBITDA Margin
0.00%
Income Tax Rate
0.00%
EPS
0.4000000000
Balance Sheet Analysis
Current Ratio
1.37
Cash Ratio
0.00
Working Capital
$2.15M
Debt to Equity
0.00
Debt to Assets
0.00%
Equity Ratio
64.75%
Cash Flow Analysis
Operating Cash Flow Ratio
70.64%
Free Cash Flow Ratio
70.64%
CapEx to Revenue
0.00%
Dividends Paid
$15.75M
Stock Buybacks
$2.25M
Total Shareholder Returns
$17.99M
Cash Position Change
1,285.7%
Key Takeaways (2024 FY)
Maintained positive net income growth despite revenue changes
Increased dividend payments by 3.34%
Increased R&D investment by 100.00%
Detailed Growth Metrics
Core Performance
Revenue
2,088.22%
Net Income
2,354.33%
EPS
2,369.14%
Operating Income
4,154.92%
Operational Efficiency
R&D Expenses
100.00%
SG&A Expenses
-4.71%
Operating Cash Flow
-80.04%
Free Cash Flow
-80.04%
Balance Sheet Health
Assets
-0.78%
Debt
-100.00%
Book Value per Share
-35.28%
Inventory
0.00%
Shareholder Returns
Dividends per Share
3.34%
Shares Outstanding
-0.70%
Long Term Trends
3Y Revenue/Share
-8.99%
5Y Revenue/Share
-28.79%
3Y Dividend/Share
9.82%
5Y Dividend/Share
-26.65%